Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    Racivir OR Racivir[TREATMENT] AND HIV [CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Completed Study Comparing Racivir and Lamivudine in Treatment-Experienced HIV Subjects
Condition: HIV Infections
Intervention: Drug: Racivir, a non-nucleoside reverse transcriptase inhibitor
2 Completed A 14-Day Study of Racivir When Used in Combination in HIV-Infected Males
Condition: HIV Infections
Intervention: Drug: Racivir
3 Completed The Safety and Effectiveness of 524W91
Condition: HIV Infections
Intervention: Drug: Emtricitabine

Indicates status has not been verified in more than two years